|87.85||-0.0300||-0.03%||Vol 182.23K||1Y Perf -3.53%|
|Jun 28th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||123.75||Analyst Rating||Moderate Buy 1.80|
|Potential %||40.87||Finscreener Ranking||★★+ 47.07|
|Insiders Trans % 3/6/12 mo.||-/-/-100||Value Ranking||★★+ 48.52|
|Insiders Value % 3/6/12 mo.||-/-/-100||Growth Ranking||★★★+ 55.76|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-100||Income Ranking||★★ 37.49|
|Price Range Ratio 52W %||17.45||Earnings Rating||Sell|
|Market Cap||4.92B||Earnings Date||25th Jul 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||25th Jul 2022|
|Estimated EPS Next Report||1.75|
|EPS Growth Next 5 Years %||10.40|
|Avg. Weekly Volume||320.06K|
|Avg. Monthly Volume||323.88K|
|Avg. Quarterly Volume||299.72K|
Crane Co. (NYSE: CR) stock closed at 87.88 per share at the end of the most recent trading day (a -0.81% change compared to the prior day closing price) with a volume of 176.22K shares and market capitalization of 4.92B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Industrial Products industry, Industrials sector and employs 11000 people. Crane Co. CEO is Max H. Mitchell.
The one-year performance of Crane Co. stock is -3.53%, while year-to-date (YTD) performance is -13.61%. CR stock has a five-year performance of 10.78%. Its 52-week range is between 82.14 and 114.87, which gives CR stock a 52-week price range ratio of 17.45%
Crane Co. currently has a PE ratio of 12.10, a price-to-book (PB) ratio of 2.88, a price-to-sale (PS) ratio of 1.54, a price to cashflow ratio of 13.30, a PEG ratio of 2.32, a ROA of 9.95%, a ROC of 16.99% and a ROE of 26.75%. The company’s profit margin is 13.47%, its EBITDA margin is 19.80%, and its revenue ttm is $3.20 Billion , which makes it $57.11 revenue per share.
Of the last four earnings reports from Crane Co., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.75 for the next earnings report. Crane Co.’s next earnings report date is 25th Jul 2022.
The consensus rating of Wall Street analysts for Crane Co. is Moderate Buy (1.8), with a target price of $123.75, which is +40.87% compared to the current price. The earnings rating for Crane Co. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Crane Co. has a dividend yield of 0.00% with a dividend per share of $0.00 and a payout ratio of 31.00%.
Crane Co. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.06, ATR14 : 3.14, CCI20 : -41.68, Chaikin Money Flow : 0.12, MACD : -2.48, Money Flow Index : 48.20, ROC : -8.91, RSI : 43.83, STOCH (14,3) : 31.16, STOCH RSI : 0.89, UO : 51.60, Williams %R : -68.84), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Crane Co. in the last 12-months were: Alejandro Alcala (Option Excercise at a value of $0), Anthony M. D'Iorio (Option Excercise at a value of $0), Christina Cristiano (Option Excercise at a value of $0), Donald G. Cook (Option Excercise at a value of $23 495), Donald G. Cook (Sold 500 shares of value $51 750 ), Edward S. Switter (Option Excercise at a value of $0), James L.L. Tullis (Option Excercise at a value of $93 980), James L.L. Tullis (Sold 2 000 shares of value $209 420 ), Kurt F. Gallo (Option Excercise at a value of $764 615), Kurt F. Gallo (Sold 15 000 shares of value $1 502 168 ), Max H. Mitchell (Option Excercise at a value of $0), Richard A. Maue (Option Excercise at a value of $1 172 453), Scott A. Grisham (Option Excercise at a value of $0), Tamara S. Polmanteer (Option Excercise at a value of $0)
Sat, 11 Jun 2022 16:00 GMT CRISPR Therapeutics Presents Positive Results from its Phase 1 COBALT-LYM Trial of CTX130 in Relapsed or Refractory T Cell Malignancies at the 2022 European Hematology Association (EHA) Congress- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.